CETUXIMAB FOR THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER

被引：1
|
作者：
Ubago, R. [1 ]
Castillo, M. A. [1 ]
Flores, S. [2 ]
Rodriguez, R. [1 ]
Beltran, C. [1 ]
机构：
[1] Agencia Evaluac Tecnol Sanitarias Andalucia, Seville, Andalucia, Spain
[2] Andalusian Agcy Hlth & Technol Assessment, Seville, Andalucia, Spain
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1104
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A433 / A434
页数：2
相关论文
共 50 条
  • [31] Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer
    Bai, Long
    Wang, Feng
    Li, Zhe-zhen
    Ren, Chao
    Zhang, Dong-sheng
    Zhao, Qi
    Lu, Yun-xin
    Wang, De-shen
    Ju, Huai-qiang
    Qiu, Miao-zhen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Xu, Rui-hua
    MEDICINE, 2016, 95 (51) : e4531
  • [32] Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer
    Tabernero, Josep
    Van Cutsem, Eric
    Diaz-Rubio, Eduardo
    Cervantes, Andres
    Humblet, Yves
    Andre, Thierry
    Van Laethem, Jean-Luc
    Soulie, Patrick
    Casado, Esther
    Verslype, Chris
    Valera, Javier Sastre
    Tortora, Giampaolo
    Ciardiello, Fortunato
    Kisker, Oliver
    de Gramont, Aimery
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5225 - 5232
  • [33] Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial
    Assenat, Eric
    Desseigne, Francoise
    Thezenas, Simon
    Viret, Frederic
    Mineur, Laurent
    Kramar, Andrew
    Samalin, Emmanuelle
    Portales, Fabienne
    Bibeau, Frederic
    Crapez-Lopez, Evelyne
    Bleuse, Jean Pierre
    Ychou, Marc
    ONCOLOGIST, 2011, 16 (11): : 1557 - 1564
  • [34] Results of the use of oxaliplatin and capecitabine plus cetuximab as first-line therapy in the treatment of patients with metastatic colorectal cancer:: First analyses
    Barroso, S.
    Sanches, E.
    Marques, Ferreira J.
    Passos, M.
    Sa, A.
    Nabico, R.
    Sottomayor, C.
    Espirito, Santo J.
    San-bento, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 74 - 75
  • [35] RESULTS OF THE USE OF OXALIPLATIN AND CAPECITABINE PLUS CETUXIMAB AS FIRST-LINE THERAPY IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER: FIRST ANALYSES
    Barroso, S.
    Sanches, E.
    Ferreira, J. M.
    Passos, M.
    Sa, A.
    Nabico, R.
    Sotto-Mayor, C.
    Santo, J. Espirito
    San-Bento, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 148 - 148
  • [36] The role of cetuximab as first-line treatment of colorectal liver metastases
    Jones, Claire
    Taylor, Mark A.
    McWilliams, Billy
    HPB, 2013, 15 (01) : 11 - 17
  • [37] Cetuximab plus chemotherapy as first-line treatment for metastatic colorectal cancer: Effect of KRAS mutation on treatment efficacy in Taiwanese patients
    Chen, M. C.
    Chiang, F. F.
    Wang, H. M.
    NEOPLASMA, 2013, 60 (05) : 561 - 567
  • [38] An update on treatment advances for the first-line therapy of metastatic colorectal cancer
    Lee, James J.
    Chu, Edward
    CANCER JOURNAL, 2007, 13 (05): : 276 - 281
  • [39] Phase III results for first-line treatment for metastatic colorectal cancer
    Kotsiliti, Eleni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (02) : 65 - 65
  • [40] First-Line Treatment Strategies for Elderly Patients with Metastatic Colorectal Cancer
    Hielke J. Meulenbeld
    Geert-Jan Creemers
    Drugs & Aging, 2007, 24 : 223 - 238
12345